Dare Bioscience shareholders approve 600,000-share increase to 2022 stock plan; re-elect directors

Dare Bioscience, Inc.

Stockholders re-elected directors Matz, Rastetter, and Steele; each received >2.4M votes for.
Ratified Haskell & White LLP as independent auditor for FY2025 with 4.5M votes for, 106K against.
Advisory say-on-pay resolution approved with 2.38M votes for, 243K against.
Approved amendment increasing shares reserved under 2022 Stock Incentive Plan by 600,000 to 1,383,333.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.